Congenital Toxoplasmosis in Humans: an Update of Worldwide Rate of Congenital Infections

Overview

Journal Parasitology

Specialty Parasitology

Date 2021 Jul 13

PMID 34254575

Citations 45

Authors

J P Dubey

F H A Murata

C K Cerqueira-Cezar

O C H Kwok

I Villena

Affiliations

Soon will be listed here.

Abstract

The morbidity due to congenital toxoplasmosis in humans is very high. Most of these infected children are likely to develop symptoms of clinical toxoplasmosis. Sequelae in fetus resulting from Toxoplasma gondii infections in women who become infected with this parasite during pregnancy can be devastating and enormous efforts are directed in some countries to prevent these consequences. Here, an update on congenital toxoplasmosis in humans, especially the rate of congenital infections in humans worldwide, is provided. Although several countries have surveillance programmes, most information on the rate of congenital transmission is from France and Brazil. Because of compulsory national screening programme in France to detect and treat women with recently acquired T. gondii infection with anti-toxoplasma therapy, the rate of congenital transmission and the severity of disease in children are declining. Infections by this parasite are widely prevalent in Brazil. The severity of clinical toxoplasmosis in Brazilian children is very high and may be associated with the genetic characteristics of T. gondii isolates prevailing in animals and humans in Brazil. Virtually little or no information is available on this topic from China, India and other countries in Asia.

Citing Articles

Impact of Experimental Congenital Toxoplasmosis on the Thyroid Gland: Histopathological and Immunobiochemical Indices Assessment.

Elgawad H, Elmehankar M, Nabih N, Sheta H, Awad S Acta Parasitol. 2025; 70(1):43.

PMID: 39853582 PMC: 11761858. DOI: 10.1007/s11686-024-00969-x.

Serological Profile of Anti- Antibodies in Liver Transplant Recipients.

Pintos G, Pires F, Zini N, da Silva R, Silva Junior F, da Silva R Trop Med Infect Dis. 2025; 10(1).

PMID: 39852669 PMC: 11769296. DOI: 10.3390/tropicalmed10010018.

Construction and biological function of gene knockout strain.

Wu K, Xie J, Liu X, Yang D, Wang Y, Zhao W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(8):1200-1209.

PMID: 39788509 PMC: 11628218. DOI: 10.11817/j.issn.1672-7347.2024.240179.

Treatment with BKI-1748 after systemic dissemination in experimentally infected pregnant sheep improves fetal and lamb mortality and morbidity and prevents congenital infection.

Sanchez-Sanchez R, Huertas-Lopez A, Largo-de la Torre A, Ferre I, Dini F, Re M Antimicrob Agents Chemother. 2025; 69(2):e0144824.

PMID: 39745365 PMC: 11823607. DOI: 10.1128/aac.01448-24.

Occurrence of Taenia species and Toxoplasma gondii in pigs slaughtered in Bujumbura city, Kayanza and Ngozi provinces, Burundi.

Minani S, Spiessens E, Labarriere A, Niyokwizera P, Gasogo A, Ntirandekura J BMC Vet Res. 2024; 20(1):589.

PMID: 39736692 PMC: 11686993. DOI: 10.1186/s12917-024-04445-6.

References

Paul M, Petersen E, Pawlowski Z, Szczapa J . Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J. 2000; 19(1):30-6. DOI: 10.1097/00006454-200001000-00007. View

El Bissati K, Levigne P, Lykins J, Adlaoui E, Barkat A, Berraho A . Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect. 2018; 7(1):165. PMC: 6160433. DOI: 10.1038/s41426-018-0164-4. View

Elbez-Rubinstein A, Ajzenberg D, Darde M, Cohen R, Dumetre A, Yera H . Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2008; 199(2):280-5. DOI: 10.1086/595793. View

Torgerson P, Mastroiacovo P . The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013; 91(7):501-8. PMC: 3699792. DOI: 10.2471/BLT.12.111732. View

Daffos F, Mirlesse V, Hohlfeld P, Jacquemard F, Thulliez P, Forestier F . Toxoplasmosis in pregnancy. Lancet. 1994; 344(8921):541. DOI: 10.1016/s0140-6736(94)91928-3. View

Blaszkowska J, Goralska K . Parasites and fungi as a threat for prenatal and postnatal human development. Ann Parasitol. 2015; 60(4):225-34. View

Robert-Gangneux F, Darde M . Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012; 25(2):264-96. PMC: 3346298. DOI: 10.1128/CMR.05013-11. View

Evengard B, Petersson K, Engman M, Wiklund S, Ivarsson S, Forsgren M . Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect. 2001; 127(1):121-7. PMC: 2869718. DOI: 10.1017/s0950268801005775. View

Philippe F, Lepetit D, Grancher M, Morel A, Henocq A . [Why monitor infants born to mothers who had a seroconversion for toxoplasmosis during pregnancy? Reality and risk of subclinical congenital toxoplasmosis in children. Review of 30,768 births]. Ann Pediatr (Paris). 1988; 35(1):5-10. View

10.

McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N . Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006; 42(10):1383-94. DOI: 10.1086/501360. View

11.

Prusa A, Kasper D, Olischar M, Husslein P, Pollak A, Hayde M . Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria. Neonatology. 2012; 103(1):27-34. DOI: 10.1159/000342625. View

12.

Avelino M, Amaral W, Rodrigues I, Rassi A, Gomes M, Costa T . Congenital toxoplasmosis and prenatal care state programs. BMC Infect Dis. 2014; 14:33. PMC: 3918215. DOI: 10.1186/1471-2334-14-33. View

13.

Villena I, Ancelle T, Delmas C, Garcia P, Brezin A, Thulliez P . Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010; 15(25). DOI: 10.2807/ese.15.25.19600-en. View

14.

Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi L . Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 2008; 13(15). PMC: 2740836. DOI: 10.2807/ese.13.15.18834-en. View

15.

Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Bonithon Kopp C . Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis. 2013; 56(9):1223-31. DOI: 10.1093/cid/cit032. View

16.

Szenasi Z, Ozsvar Z, Nagy E, Jeszenszky M, Szabo J, GELLEN J . Prevention of congenital toxoplasmosis in Szeged, Hungary. Int J Epidemiol. 1997; 26(2):428-35. DOI: 10.1093/ije/26.2.428. View

17.

Stillwaggon E, Carrier C, Sautter M, McLeod R . Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011; 5(9):e1333. PMC: 3181241. DOI: 10.1371/journal.pntd.0001333. View

18.

Conceicao A, Belucik D, Missio L, Gustavo Brenner L, Henrique Monteiro M, Ribeiro K . Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak. Ophthalmology. 2021; 128(9):1346-1355. DOI: 10.1016/j.ophtha.2021.03.009. View

19.

Wolf A, Cowen D, Paige B . HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS. Science. 1939; 89(2306):226-7. DOI: 10.1126/science.89.2306.226. View

20.

DESMONTS G, Couvreur J . Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974; 290(20):1110-6. DOI: 10.1056/NEJM197405162902003. View